Stryker Corporation (SYK)

Stryker Corporation is trading at $307.08, up 3.19% on the session. The 50 day average sits at $297.28 and the 200 day at $325.90, which puts the stock in a downtrend. RSI is at 58.1, which reads as strong, and MACD is bullish crossover. Volume is average.

The nearest support is around $271.67 with resistance near $343.90, so that band frames the current range. Average daily movement is roughly $8.39, or about 2.7% of the share price, which is what any stop placement has to allow for. The overall health score of 57 out of 100 combines a trend score of 23, momentum of 83 and a risk score of 73.

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.